Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 135 (ZNF135) is a C2H2-type zinc finger transcription factor featuring a Krüppel-associated box (KRAB) domain, encoded on chromosome 19q13.43[2]. It is predicted to function as a DNA-binding transcription factor, specifically regulating transcription mediated by RNA polymerase II and is thought to influence cell morphology and cytoskeletal organization, possibly via transcriptional regulation of key genes[4][5][6]. ZNF135 belongs to a large family of zinc finger proteins involved in a spectrum of biological processes including gene expression, development, and differentiation. While the broader zinc finger family is implicated in disease processes such as cancer, neurodegenerative diseases, and immune response disorders[1][3], there is currently no direct evidence indicating ZNF135's involvement as a therapeutic target or in drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 135 (ZNF135).